The complement system of homeothermic animals plays an important role in protection against bacterial infection. In the nonimmune host, this primary defense is mediated largely through activation of the alternative complement pathway, whereas in immune individuals, both classical and alternative pathways participate. Complement can produce a direct bactericidal reaction and also has an opsonic function in the interaction between bacteria and phagocytic cells (4) . In poikilothermic teleost fish, where both pathways of complement activation have been demonstrated (8, 12) , the direct bactericidal reaction would seem to be of particular importance, since fish phagocytes appear to lack C3 receptors (15) . Moreover, fish produce antibodies of the immunoglobulin M class only (3) ; by analogy, with homeotherms, in which this antibody class serves as the best complementfixing antibody as well as the major bacteriolytic antibody, complement-mediated bacteriolysis might be the primary antibacterial role of fish antibodies.
Clearly, if an invading organism can resist the bactericidal activity of complement in nonimmune serum, it has a survival and, hence, a pathogenic advantage. In the case of gramnegative pathogens of homeothermic animals, this virulence property is conferred by either normal lipopolysaccharide (LPS) or protein components of the outer membrane (OM) (1) . In the immune animal, the binding of antibodies to cell surface components can overcome this resistance.
Aeromonas salmonicida is an important pathogen of salmonid fishes, producing the systemic disease furunculosis. The principal virulence factor of this pathogen appears to be a 49,000-molecular-weight (MW) surface protein (A-protein) (5, 14) . Impermeant labeling studies have shown that A-protein appears to cover most of the surface of virulent A. salmonicida (6) , although some LPS may also be exposed. In a previous paper, we showed that attenuated mutants could be readily obtained by culture at an elevated temperature (5). Here we describe changes in the bacterial cell envelope of these mutants associated with this attenuation of virulence and report on the role of both the Aprotein and LPS in the resistance of A. salmonicida to serum killing.
MATERIALS AND METHODS
Bacterial strain. The strains used in this study are listed in Table 1 . Virulent and attenuated A-proteindeficient strains will henceforth be referred to as A' and A-strains, respectively. The A-strains were obtained by growth of A' strains at a high temperature, as described previously (5) . LPS-deficient (LPS-) mutants A449-3R and A451-3R were derived from A-strains in this study by selecting for clones which were simultaneously resistant to A. salmonicida bacteriophages 37, 40, 54, and 55 (11) . The detailed isolation and characterization of these mutants will be described elsewhere (manuscript in preparation). Strains A450-1 and A451-1 were spontaneous attenuated derivatives of A450 and A451, respectively, which had become simultaneously deficient in both A-protein and LPS. As was expected, all A-LPS-mutants were avirulent for coho salmon when the procedure described by Ishiguro et al. (5) was used. Stock cultures were maintained at -70°C in 15% (vol/vol) glycerolTrypticase soy broth (BBL Microbiology Systems). Assay of antibody levels. Agglutinating antibody titers in human, rabbit, and trout sera were obtained with a microtiter plate assay with a dense suspension of strain A450-2 in PBS. (A' strains of A. salmonicida was autoagglutinating and were not used.) Immune rabbit serum was also tested with a solid-phase enzyme-linked immunosorbent assay for A-protein and LPS. The developing antibody was a 1/50 dilution of affinity-purified goat anti-rabbit immunoglobulin Galkaline phosphatase (13) .
Bacteria survival in serum. The survival of logarithmic-phase bacteria in serum was measured. To 0.4 ml of serum was added 0.1 ml of a suspension in PBS of bacteria in logarithmic phase (4 to 5 h of culture in Trypticase soy broth), adjusted by optical density to about 5 x 10' cells per ml. Viable counts were made at hourly intervals during incubation at 22°C up to 3 h by the Miles-Misra method (8) after serial dilution in PBS. Results are expressed as the percentage of bacteria inoculated that survived after a given time. Controls (bacteria in PBS) showed no significant change in viable count over the incubation period. In some assays, the same serum previously heated at 45°C for 30 min (trout) (2) or at 56°C for 30 min (rabbit) to destroy complement activity was used. In other assays, Ca2" and Mg2+ were removed from the serum in the assay mixture by chelation with 10 mM EDTA (Sigma Chemical Co.). This treatment also inhibits complement activity (7, 9) . Serum was usually used on the day of collection, and a control serum-sensitive strain of Salmonella typhimurium was used in each series of assays to test for bactericidal activity. For technical reasons, immune serum was stored at 4°C for 24 h before testing. Although active against S. typhimurium, immune serum was mixed 1:1 with fresh normal serum just before use as an added precaution.
Radiolabeling of A. salmonicida LPS. Several colonies of A. salmonicida strains previously grown on Trypticase soy agar were suspended in 0.5 ml of sterile saline, and 0.1-ml samples were evenly spread onto fresh Trypticase soy agar plates containing 100 p.Ci of carrier-free [32p]PO4. After 4 days of growth at 20°C, cells were scraped from the agar, washed with 30 ml of Davis minimal medium, and resuspended to an optical density of 4.0 at 650 nm in the same medium. A small sample was assayed for radioactivity to determine the extent of 32P radiolabeling.
OM isolation. Ten milliliters of the labeled cell suspensions were broken by two passes through a French pressure cell. The broken suspension was diluted threefold in cold David minimal medium, and unbroken cells were removed by centrifugation at 3,000 x g. The supernatants were further centrifuged at 40,000 x g for 30 min, and the membrane pellets were stored at -20°C. Thawed pellets were extracted with 0.5% sodium lauryl sarcosinate for 30 min at room temperature, diluted twofold with cold minimal medium, and centrifuged at 40,000 x g for 45 min. Extraction with 4 M KCI instead of sodium lauryl sarcosinate was equally effective in removing 32p_ labeled nucleic acid contaminants. OMs were resuspended by homogenization in 0.5 ml of 50 mM phosphate buffer, and a 10-ml sample was assayed for radioactivity. The presence of 32P-labeled LPS was detected by autoradiography after separating the OM components on 12% sodium dodecyl sulfate (SDS)-polyacrylamide gels as previously described (6) . Gels were also stained for proteins with Fig. 2A . In human serum, both strains grew logarithmically over the 3-h incubation period, with an approximate sixfold increase in viable numbers. These strains also grew in rabbit serum, although less rapidly than in human serum. In normal trout serum, a slight reduction of strain A449 and a somewhat greater reduction of A449-3 was observed. In several experiments, viable numbers after 3 h of the Aderivative A449-3 were lower than those of A449. Normal trout serum and normal human serum had agglutinating antibody titers of 1/16 to 1/32. With strains A450 and A450-2, very similar results were obtained, both strains being resistant to killing by human and rabbit sera. (The data shown in Fig. 3B for immune serum were identical to that obtained with normal rabbit serum.) In normal trout serum, the A' strain was of intermediate resistance, whereas the Astrain was more sensitive (Fig. 3B) . In contrast, strain A451 was resistant to serum killing (Fig.  2B) , whereas the A-derivative was sensitive, showing survival in rabbit and trout sera of less than 10% after 3 h (Fig. 2B) .
To determine whether differences in serum survival among strains were due to nutritional rather than bactericidal factors, we measured survival in serum heated to destroy complement. These results (Table 2) showed that there were no significant differences between the growth of A' strains and their A-derivatives.
In all types of sera, the LPS mutants 449-3R, 450-1, and 451-3R were completely killed within 1 h ( Fig. 2A and B and 3B ), but all grew in heated serum (Table 2) , although less well than did their parent strains. The bactericidal activity of normal serum for these three sensitive aeromonads was removed with 10 mM EDTA (data not shown).
Survival in immune serum. Results of immune serum survival experiments with strains A449, A449-3, A450, and A450-2 are shown in Fig. 3 . The rabbit serum contained high titers of antibody to A-protein (1:100,000) and LPS (1:1,000) and an agglutination titer against A450-2 of 1:32. The agglutination titer of trout serum against A450-2 was 1:11,000. Immune rabbit serum did not inhibit growth of any of these strains. In immune trout serum, there was a slight reduction of strains A449 and A450, as was shown in normal trout serum. Both strains A449-3 and A450-2 were, however, rapidly killed by immune trout serum. The numbers of strain A451 also increased during incubation in immune rabbit serum (Fig. 4) . This strain was also resistant to killing by immune trout serum. In the case of strain A451-3, the number of viable cells was reduced to 10% during the 3 h of incubation in immune rabbit serum, and this strain was rapidly killed in immune trout serum. The results in Fig.  3 and 4 show that strains 449-3R, 450-1, and 451-3R were killed within 1 h in both immune sera.
DISCUSSION
This study has shown that virulent strains of A. salmonicida display high or intermediate resistance to the bactericidal activity of complement in both the presence and absence of specific antibodies. This undoubtedly contributes to their potential to survive, proliferate, and produce disease in the infected host. This ability of A. salmonicida to resist complement killing clearly resides in its surface structure (Table 3) . Indeed, it would appear that this bacterium has a doubly protective barrier, since both A-protein and LPS somehow prevent access of membrane lytic complement components to their membrane targets. The major contribution of LPS to serum resistance is mediated by the O-antigen polysaccharide composition of the molecule. This is illustrated by the results obtained with A-LPSstrains A449-3R, A450-1, A451-3R, and A451-1. These strains clearly have an altered LPS structure ( Fig. 1 ed killing. Indeed, in immune trout serum containing high levels of antibody, all A-strains were quickly killed, whereas there was no enhanced killing of their A' parents. In these A' strains, A-layer must function as a protective physical barrier to the access of the lytic complement components to the cytoplasmic membrane. These results suggest that an elevated antibody level to A. salmonicida by itself is unlikely to provide the fish with protective immunity against virulent strains and perhaps provides an explanation for those various reports of absence of protective immunity in vaccinated animals which have significant titers of agglutinating antibody (10) . Indeed, the continued use of agglutination antibody titer as the sole measure of vaccine efficacy must be seriously questioned in the case of this pathogen. The fact that rabbit serum containing antibodies reacting with A-protein and LPS did not show bactericidal activity might be explained if this serum contained predominantly IgG antibodies, which are less efficient in complement fixation.
In conclusion, this study has defined an important role for LPS and the A-layer in the virulence of A. salmonicida. However, since loss of virulence does not coincide with a loss of serum resistance but does coincide with loss of A-layer, there are probably other important virulence roles for A-layer. Analysis of the fate of A' and A-strains in vivo (C. B. Munn and T. J.
Trust, unpublished data) indicates that the principal difference between them may be their ability to survive within the phagocytic organs;
A-layer would appear to be a crucial factor in this survival. This study also suggests that the development of protective immunity after administration of A. salmonicida vaccines probably results from activation of the cell-mediated arm of the immune response.
